High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support
- 1 June 1989
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 23 (6) , 377-383
- https://doi.org/10.1007/bf00435840
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacokinetics of high-dose melphalan in children and adultsCancer Chemotherapy and Pharmacology, 1986
- Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.Journal of Clinical Oncology, 1983
- Pharmacokinetics of melphalan in children following high-dose intravenous injectionCancer Chemotherapy and Pharmacology, 1983
- Application of a simple high—performance liquid chomatographic method for the determination of melphalan in the presence of its hydrolysis productsJournal of Chromatography A, 1979
- Kinetics of intravenous melphalanClinical Pharmacology & Therapeutics, 1979
- Chronic Renal Failure in Children Treated with Methyl CCNUNew England Journal of Medicine, 1979
- Patterns of Resistance and Therapeutic Synergism among Alkylating Agents1Published by S. Karger AG ,1977
- ACUTE LETHAL CARDITIS CAUSED BY HIGH-DOSE COMBINATION CHEMOTHERAPYThe Lancet, 1976
- Pathology of high dose intermittent cyclophosphamide therapyHuman Pathology, 1975
- Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.1970